CAIRO, Stefano Enrico
 Distribuzione geografica
Continente #
NA - Nord America 3.801
AS - Asia 1.927
EU - Europa 770
SA - Sud America 381
Continente sconosciuto - Info sul continente non disponibili 93
AF - Africa 66
OC - Oceania 2
Totale 7.040
Nazione #
US - Stati Uniti d'America 3.705
SG - Singapore 724
CN - Cina 430
BR - Brasile 320
VN - Vietnam 228
HK - Hong Kong 168
IT - Italia 150
DE - Germania 124
SE - Svezia 105
UA - Ucraina 102
GB - Regno Unito 84
TR - Turchia 83
BD - Bangladesh 75
FR - Francia 53
CA - Canada 50
JP - Giappone 49
RU - Federazione Russa 44
IN - India 42
FI - Finlandia 35
MX - Messico 32
ID - Indonesia 27
ZA - Sudafrica 22
AR - Argentina 18
MA - Marocco 17
PK - Pakistan 16
ES - Italia 15
EC - Ecuador 13
IQ - Iraq 12
PL - Polonia 12
CO - Colombia 11
NL - Olanda 10
UZ - Uzbekistan 9
VE - Venezuela 9
AT - Austria 8
IR - Iran 8
SA - Arabia Saudita 8
CZ - Repubblica Ceca 7
KR - Corea 7
LT - Lituania 6
PH - Filippine 6
DZ - Algeria 5
EG - Egitto 5
NP - Nepal 5
CR - Costa Rica 4
IL - Israele 4
KE - Kenya 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
BE - Belgio 3
DO - Repubblica Dominicana 3
JO - Giordania 3
MY - Malesia 3
PS - Palestinian Territory 3
TW - Taiwan 3
UY - Uruguay 3
AL - Albania 2
CL - Cile 2
HN - Honduras 2
HU - Ungheria 2
KG - Kirghizistan 2
LB - Libano 2
MG - Madagascar 2
MM - Myanmar 2
NI - Nicaragua 2
OM - Oman 2
PE - Perù 2
PR - Porto Rico 2
RS - Serbia 2
SN - Senegal 2
AU - Australia 1
BF - Burkina Faso 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
ET - Etiopia 1
EU - Europa 1
GR - Grecia 1
GY - Guiana 1
JM - Giamaica 1
KI - Kiribati 1
MD - Moldavia 1
NG - Nigeria 1
NO - Norvegia 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TL - Timor Orientale 1
TZ - Tanzania 1
Totale 6.948
Città #
Ashburn 431
Singapore 425
San Jose 340
Fairfield 322
Woodbridge 286
Santa Clara 174
Beijing 170
Hong Kong 159
Houston 159
Chandler 157
Jacksonville 134
Seattle 131
Ann Arbor 126
Wilmington 121
Council Bluffs 103
Cambridge 102
New York 81
Ho Chi Minh City 77
Dallas 75
Los Angeles 54
Hanoi 51
Tokyo 49
Izmir 47
Nanjing 37
Boardman 36
Dearborn 35
Lauterbourg 30
Princeton 29
São Paulo 29
Shanghai 28
Milan 26
Ferrara 22
Mexico City 22
Bremen 21
Montreal 20
San Diego 19
Jakarta 18
Brooklyn 16
Chicago 16
Falls Church 16
London 16
Orem 16
Phoenix 16
Toronto 16
Munich 15
Augusta 14
Da Nang 14
The Dalles 14
Chennai 13
Nanchang 13
Stockholm 13
Rio de Janeiro 12
Johannesburg 11
Warsaw 11
Ankara 10
Atlanta 10
Curitiba 10
Hebei 10
Rome 10
San Francisco 10
Haiphong 9
Manchester 9
Moscow 9
Nuremberg 9
Tashkent 9
Columbus 8
Guangzhou 8
Poplar 8
Shenyang 8
Belo Horizonte 7
Boston 7
Campinas 7
Denver 7
Des Moines 7
Jiaxing 7
Ardabil 6
Bologna 6
Brasília 6
Frankfurt am Main 6
Hangzhou 6
Mumbai 6
Ninh Bình 6
Norwalk 6
Addison 5
Amsterdam 5
Baghdad 5
Biên Hòa 5
Buffalo 5
Caracas 5
Changsha 5
Fes 5
Guarulhos 5
Newark 5
Osasco 5
Philadelphia 5
Quito 5
Redwood City 5
Brno 4
Bến Tre 4
Cairo 4
Totale 4.697
Nome #
Abstract P5-06-04: The PARP inhibitor niraparib demonstrated activity in patient-derived triple-negative breast cancer xenograft models with high homologous recombination deficiency (HRD) score 266
Early activation of IFN/STAT signaling in tumor cells of patient-derived triple negative breast cancer xenografts predicts tumor sensitivity to chemotherapy 264
Functional characterization of the OFD1 protein reveals a nuclear localization and physical interaction with subunits of a chromatin remodeling complex 245
Functional genomics of the B-box gene family reveals a possible role in subcellular compartmentalization 240
Activation of Wnt and Myc signaling in hepatoblastoma 238
Reprogramming of miRNA networks in cancer and leukemia 231
CA3-Classification de l’hépatoblastome par l'étude en microarray du profil d’expression génétique 227
Deficiency of multidrug resistance 2 contributes to cell transformation through oxidative stress 223
Mlx, a new Max-like bHLHZip family member: the center stage of a novel transcription factors regulatory pathway? 219
Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer 214
The genomic landscape of hepatoblastoma and their progenies with HCC-like features 211
Heterogeneous expression of EPCAM in human circulating tumour cells from patient-derived xenografts 208
PML interacts with Myc, and Myc target gene expression is altered in PML-null fibroblasts 205
How transient becomes stable: an epigenetic switch linking liver inflammation and tumorigenesis 204
TAK1 suppresses a NEMO-dependent but NF-kappaB-independent pathway to liver cancer 201
Preferential localization of tyrosine-phosphorylated paxillin in focal adhesions 190
The MET Inhibitor AZD6094 (Savolitinib, HMPL-504) induces regression in papillary renal cell carcinoma patient-derived xenograft models 187
LIM-only protein FHL2 activates NF-κB signaling in the control of liver regeneration and hepatocarcinogenesis 186
The four and a half LIM-only protein 2 regulates liver homeostasis and contributes to carcinogenesis 184
The tripartite motif family identifies cell compartments 179
Hepatic Stem-like Phenotype and Interplay of Wnt/β-Catenin and Myc Signaling in Aggressive Childhood Liver Cancer 179
The hepatitis B virus X protein functionally interacts with CREB-binding protein/p300 in the regulation of CREB-mediated transcription 170
The sialyl-glycolipid stage-specific embryonic antigen 4 marks a subpopulation of chemotherapy-resistant breast cancer cells with mesenchymal features 165
Myc target miRs and liver cancer: small molecules to get Myc sick 159
Targeting the Vav1/miR‐29b axis as a potential approach for treating selected molecular subtypes of triple‐negative breast cancer 153
Subset of Suz12/PRC2 target genes is activated during hepatitis B virus replication and liver carcinogenesis associated with HBV X protein 151
Genomic analysis of the TRIM family reveals two groups of genes with distinct evolutionary properties 148
Abstract B11: A panel of patient-derived xenografts for preclinical efficacy studies in various breast cancer molecular subtypes 141
Activation of IFN/STAT1 signalling predicts response to chemotherapy in oestrogen receptor-negative breast cancer 133
A KRAS-responsive long non-coding RNA controls microRNA processing 130
Patient-derived xenografts from pediatric liver cancer predict tumor recurrence and advise clinical management 128
Expression profiling and CGH array as prognostic tools in hepatoblastoma 105
Vav1 Selectively Down-Regulates Akt2 through miR-29b in Certain Breast Tumors with Triple Negative Phenotype 98
Functional evaluation of interferon/STAT1 pathway activation in response to genotoxic treatment 90
Establishment and characterization of circulating tumor cell-derived xenografts in non-small cell lung cancer 87
SSEA4 AND ST3GAL2 AS CHEMOTHERAPEUTIC DRUG RESPONSE BIOMARKERS 87
A panel of pediatric liver cancer patient-derived xenografts to improve stratification of children with hepatoblastoma 84
null 83
The PARP inhibitor niraparib demonstrates robust activity in a subset of patient-derived triple-negative breast cancer xenograft models 76
null 76
Understanding breast cancer resistance to chemotherapy: Characterization of cancer cell sub-populations in residual and relapsed tumors 65
Tbx3 is a downstream target of the Wnt/$\beta$-catenin pathway and a critical mediator of $\beta$-catenin survival functions in liver cancer 57
Wnt signaling and hepatocarcinogenesis: The hepatoblastoma model 56
Polo-like kinase 1 inhibition suppresses hepatitis B virus X protein-induced transformation in an in vitro model of liver cancer progression 49
Preclinical evaluation of the PARP inhibitor niraparib and cytotoxic chemotherapy alone or in combination in a panel of 25 triple-negative breast cancer PDX models: Relevance of BRCA mutations, HRD status and other biomarkers 48
Totale 7.040
Categoria #
all - tutte 33.555
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.555


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022272 0 0 16 7 31 30 12 26 11 38 33 68
2022/2023361 30 33 27 36 70 45 11 29 43 5 20 12
2023/2024231 14 26 7 6 7 52 5 19 6 10 7 72
2024/2025960 21 14 60 20 124 72 61 72 167 94 171 84
2025/20262.784 265 113 247 280 449 158 412 139 223 259 171 68
2026/2027348 81 170 97 0 0 0 0 0 0 0 0 0
Totale 7.040